Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Net Margin (2010 - 2026)

Exelixis (EXEL) posted quarterly Net Margin of 34.46% for Q2 2026, up 572.0% year-over-year from 5.13% in Q2 2025, and down 15.64% quarter-over-quarter from 40.85% in Q1 2026.

Analysis

Exelixis (EXEL) Net Margin (2010 - 2026) Analysis & Trends

Exelixis' Net Margin history runs 17 years deep, the most recent figure standing at 34.46% for Q2 2026.

  • In Q2 2026, Net Margin rose 572.0% year-over-year to 34.46%; the TTM figure through Apr 2026 stood at 35.08% (up 709.0% YoY), while the FY2026 annual figure was 33.73%, up 969.0% from the prior year.
  • Net Margin for Q2 2026 stood at 34.46%, down from 40.85% in the prior quarter.
  • The five-year high for Net Margin was 40.85% in Q1 2026, with the low at 7.12% in Q4 2022.
  • The 5-year median for Net Margin is 19.26% (2022), against an average of 20.69%.
  • Peak annual rise in Net Margin reached 2495 bps in 2023, while the deepest fall reached 1756 bps in 2023.
  • Exelixis' Net Margin stood at 7.12% in 2022, then jumped by 350 bps to 17.83% in 2023, then gained by 23 bps to 21.87% in 2024, then jumped by 48 bps to 32.38% in 2025, then gained by 6 bps to 34.46% in 2026.
  • Business Quant data shows EXEL's Net Margin at 34.46% in Q2 2026, 40.85% in Q1 2026, and 32.38% in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 30.23%
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 31.16%
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -539.31%
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.90%
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 12.74%
8 Royalty Pharma 28.45 Bn 27.61 Bn - 12.09%
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -3.12%
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 33.73%
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 33.73%
Apr 3, 2026 34.46%
Jan 2, 2026 40.85%
Oct 3, 2025 32.38%
Jul 4, 2025 32.53%
Apr 4, 2025 28.74%
Jan 3, 2025 24.68%
Sep 27, 2024 21.87%
Jun 28, 2024 35.49%
Mar 29, 2024 8.78%
Dec 29, 2023 17.83%
Sep 29, 2023 0.22%
Jun 30, 2023 17.28%
Mar 31, 2023 9.79%
Dec 30, 2022 -7.12%
Sep 30, 2022 17.78%
Jul 1, 2022 16.85%
Apr 1, 2022 19.26%
Oct 1, 2021 11.63%
Jul 2, 2021 24.95%